Kinaxis (TSE:KXS) Given a C$200.00 Price Target at National Bank Financial

Kinaxis (TSE:KXSGet Free Report) has been given a C$200.00 price target by research analysts at National Bank Financial in a research report issued to clients and investors on Monday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bank Financial’s target price would suggest a potential upside of 29.41% from the company’s previous close.

Other analysts also recently issued research reports about the company. Royal Bank Of Canada raised their price target on Kinaxis from C$200.00 to C$210.00 and gave the stock an “outperform” rating in a report on Friday, May 8th. Stifel Nicolaus cut their target price on Kinaxis from C$245.00 to C$200.00 and set a “buy” rating on the stock in a research note on Wednesday, May 6th. Canadian Imperial Bank of Commerce upped their price target on shares of Kinaxis from C$173.00 to C$205.00 in a research report on Friday, June 5th. Finally, BMO Capital Markets increased their price objective on shares of Kinaxis from C$180.00 to C$185.00 in a report on Friday, May 8th. Six equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of C$200.00.

Read Our Latest Analysis on Kinaxis

Kinaxis Stock Performance

Kinaxis stock traded up C$0.01 during mid-day trading on Monday, reaching C$154.55. The company’s stock had a trading volume of 31,725 shares, compared to its average volume of 124,873. The company has a current ratio of 1.72, a quick ratio of 2.29 and a debt-to-equity ratio of 12.15. Kinaxis has a twelve month low of C$117.22 and a twelve month high of C$212.45. The business has a 50 day moving average price of C$152.87 and a 200-day moving average price of C$146.05. The firm has a market cap of C$4.22 billion, a price-to-earnings ratio of 52.57, a PEG ratio of 3.60 and a beta of 0.73.

Kinaxis (TSE:KXSGet Free Report) last issued its earnings results on Wednesday, May 6th. The company reported C$1.45 earnings per share (EPS) for the quarter. Kinaxis had a net margin of 14.48% and a return on equity of 19.72%. The firm had revenue of C$230.19 million for the quarter. Sell-side analysts predict that Kinaxis will post 4.2526231 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Conrad John Mandala sold 30,000 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of C$148.10, for a total transaction of C$4,443,000.00. Following the transaction, the insider directly owned 820 shares of the company’s stock, valued at approximately C$121,442. This trade represents a 97.34% decrease in their ownership of the stock. Also, Director Robert G. Courteau sold 5,010 shares of Kinaxis stock in a transaction dated Friday, May 29th. The shares were sold at an average price of C$151.39, for a total transaction of C$758,463.90. Following the sale, the director owned 32,945 shares in the company, valued at approximately C$4,987,543.55. This represents a 13.20% decrease in their ownership of the stock. Insiders have sold a total of 35,934 shares of company stock valued at $5,328,181 in the last quarter. 1.20% of the stock is currently owned by insiders.

Kinaxis Company Profile

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

See Also

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.